Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders
Author:
Publisher
Springer Singapore
Link
http://link.springer.com/content/pdf/10.1007/978-981-10-3233-2_12
Reference190 articles.
1. Abe, A., Katsumi, A., Kobayashi, M., et al. (2012). A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22). Cancer Genetics, 205(11), 608–611.
2. Allen, C., Hills, R. K., Lamb, K., et al. (2013). The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. Leukemia, 27(9), 1891–1901.
3. Alpermann, T., Haferlach, C., Eder, C., et al. (2015). AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8 % of the patients. Leukemia Research, 39(3), 265–272.
4. Antony-Debré, I., Duployez, N., Bucci, M., et al. (2016). Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia. Leukemia, 30(4), 999–1002.
5. Appelbaum, F. R., Kopecky, K. J., Tallman, M. S., et al. (2006). The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. British Journal of Haematology, 135(2), 165–173.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM);Blood Cancer Journal;2024-02-05
2. Deletion 16q Involving Partial 3’ Cbfbeta with an Additional Triple Trisomy; a Novel Finding in Aml M4 Eosinophilia; a Distinct Sub-Class;2024
3. The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment;Blood Reviews;2023-11
4. Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16);BMC Cancer;2023-05-25
5. Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia;Haematologica;2022-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3